Lipocine Inc (LPCN)
4.75
+0.04
(+0.85%)
USD |
NASDAQ |
May 02, 16:00
4.60
-0.15
(-3.16%)
After-Hours: 06:27
Lipocine Max Drawdown (5Y): 98.27% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.27% |
March 31, 2024 | 98.27% |
February 29, 2024 | 98.27% |
January 31, 2024 | 98.27% |
December 31, 2023 | 98.27% |
November 30, 2023 | 98.27% |
October 31, 2023 | 98.27% |
September 30, 2023 | 98.27% |
August 31, 2023 | 98.27% |
July 31, 2023 | 98.27% |
June 30, 2023 | 98.27% |
May 31, 2023 | 98.27% |
April 30, 2023 | 98.27% |
March 31, 2023 | 98.27% |
February 28, 2023 | 98.27% |
January 31, 2023 | 98.27% |
December 31, 2022 | 98.27% |
November 30, 2022 | 98.27% |
October 31, 2022 | 98.27% |
September 30, 2022 | 98.27% |
August 31, 2022 | 98.27% |
July 31, 2022 | 98.27% |
June 30, 2022 | 98.27% |
May 31, 2022 | 98.27% |
April 30, 2022 | 98.27% |
Date | Value |
---|---|
March 31, 2022 | 98.27% |
February 28, 2022 | 98.27% |
January 31, 2022 | 98.27% |
December 31, 2021 | 98.27% |
November 30, 2021 | 98.27% |
October 31, 2021 | 98.27% |
September 30, 2021 | 98.27% |
August 31, 2021 | 98.27% |
July 31, 2021 | 98.27% |
June 30, 2021 | 98.27% |
May 31, 2021 | 98.27% |
April 30, 2021 | 98.27% |
March 31, 2021 | 98.27% |
February 28, 2021 | 98.27% |
January 31, 2021 | 98.27% |
December 31, 2020 | 98.27% |
November 30, 2020 | 98.27% |
October 31, 2020 | 98.27% |
September 30, 2020 | 98.27% |
August 31, 2020 | 98.27% |
July 31, 2020 | 98.27% |
June 30, 2020 | 98.27% |
May 31, 2020 | 98.27% |
April 30, 2020 | 98.27% |
March 31, 2020 | 98.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.47%
Minimum
May 2019
98.27%
Maximum
Mar 2020
98.08%
Average
98.27%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Alpine Immune Sciences Inc | 97.33% |
Eliem Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -46.18 |
Beta (5Y) | 1.108 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 91.35% |
Historical Sharpe Ratio (5Y) | -0.3704 |
Historical Sortino (5Y) | -0.618 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.74% |